Ayala Pharmaceuticals (NASDAQ:ADXS) Earns Sell Rating From Analysts at StockNews.com
Ayala Pharmaceuticals (NASDAQ:ADXS) Earns Sell Rating From Analysts at StockNews.com
Equities research analysts at StockNews.com assumed coverage on shares of Ayala Pharmaceuticals (NASDAQ:ADXS – Get Rating) in a report released on Monday. The firm set a "sell" rating on the stock.
Ayala Pharmaceuticals Price Performance
Ayala Pharmaceuticals stock opened at $1.55 on Monday. Ayala Pharmaceuticals has a 52 week low of $1.00 and a 52 week high of $10.80.
Get Ayala Pharmaceuticals alerts:Ayala Pharmaceuticals Company Profile
(Get Rating)
Advaxis, Inc is a biotechnology company, which engages in the discovery, development and commercialization of cancer immunotherapies. It manages platform technology that utilizes live attenuated Listeria monocytogenes bioengineered to secrete antigen or adjuvant fusion proteins. The firm has four franchises in various stages of clinical and pre-clinical development, namely: HPV-associated cancers, prostate cancer, neoantigen therapy and hotspot mutation therapy.
Featured Articles
- Get a free copy of the StockNews.com research report on Ayala Pharmaceuticals (ADXS)
- MarketBeat Week in Review – 3/13 – 3/17
- This Small Tech With Big Growth Prospects Is Nearing A Buy Point
- Don't Chase FedEx Higher, Wait For The Pullback
- 3 Stocks For A Defensive Tech Portfolio
- Milk the Dividends on These 3 Cash Cows
Receive News & Ratings for Ayala Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ayala Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
Equities research analysts at StockNews.com assumed coverage on shares of Ayala Pharmaceuticals (NASDAQ:ADXS – Get Rating) in a report released on Monday. The firm set a "sell" rating on the stock.
StockNews.com的股票研究分析師假設對以下股票進行了報道 阿亞拉制藥（納斯達克股票代碼：ADXS — 獲取評級） 在週一發佈的一份報告中。該公司對該股設定了 “賣出” 評級。
Ayala Pharmaceuticals Price Performance
阿亞拉制藥的價格表現
Ayala Pharmaceuticals stock opened at $1.55 on Monday. Ayala Pharmaceuticals has a 52 week low of $1.00 and a 52 week high of $10.80.
週一，阿亞拉制藥股開盤價爲1.55美元。阿亞拉制藥的52周低點爲1.00美元，爲52周的高點爲10.80美元。
Ayala Pharmaceuticals Company Profile
阿亞拉制藥公司簡介
(Get Rating)
（獲取評級）
Advaxis, Inc is a biotechnology company, which engages in the discovery, development and commercialization of cancer immunotherapies. It manages platform technology that utilizes live attenuated Listeria monocytogenes bioengineered to secrete antigen or adjuvant fusion proteins. The firm has four franchises in various stages of clinical and pre-clinical development, namely: HPV-associated cancers, prostate cancer, neoantigen therapy and hotspot mutation therapy.
Advaxis, Inc是一家生物技術公司，從事癌症免疫療法的發現、開發和商業化。它管理的平臺技術利用活的減毒單核細胞增生李斯特菌分泌抗原或輔助融合蛋白。該公司擁有四個處於不同臨床和臨床前開發階段的特許經營權，即：人乳頭瘤病毒相關癌症、前列腺癌、新抗原療法和熱點突變療法。
Featured Articles
精選文章
- Get a free copy of the StockNews.com research report on Ayala Pharmaceuticals (ADXS)
- MarketBeat Week in Review – 3/13 – 3/17
- This Small Tech With Big Growth Prospects Is Nearing A Buy Point
- Don't Chase FedEx Higher, Wait For The Pullback
- 3 Stocks For A Defensive Tech Portfolio
- Milk the Dividends on These 3 Cash Cows
- 免費獲取 StockNews.com 關於阿亞拉制藥（ADXS）的研究報告的副本
- MarketBeat Week 回顧 — 3 月 13 日 — 3 月 17 日
- 這傢俱有巨大增長前景的小型科技公司已接近買入點
- 不要追高聯邦快遞，等着回調
- 防禦性科技投資組合的3只股票
- 在這 3 頭搖錢樹身上擠出股息
Receive News & Ratings for Ayala Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ayala Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
接收《阿亞拉制藥日報》的新聞和評級 -在下面輸入您的電子郵件地址，通過Marketbeat.com的免費每日電子郵件時事通訊接收Ayala Pharmicals及相關公司的最新新聞和分析師評級的簡明每日摘要。
譯文內容由第三人軟體翻譯。
風險及免責聲明
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能，分享給你的好友吧